VIRMA and non-small cell lung carcinoma: demonstrated that silencing KIAA1429 via siRNA augments the sensitivity of NSCLC cells to the ferroptosis inducer erastin, characterized by increased intracellular Fe2+ and ROS accumulation, reduced levels of GSH and MDA, elevated PTGS2 expression, and decreased GPX4 and FTH1 protein levels (156).